Supplementary Figure 7: Reverse phase protein analysis (RPPA) of tofacitinib and R406-treated PSC-WA.
From: White-to-brown metabolic conversion of human adipocytes by JAK inhibition
Cells were collected 20’ after addition of compounds to PSC-WA and processed for RPPA. Data shown is relative to DMSO. All 51 antibodies recognized the phospho-isoforms of indicated proteins. 3 antibodies did not reach detection threshold and were excluded from graph. Data from one experiment (n = 3 biological replicates) representative of 2 independent experiments. Values are mean ± s.d. of three biological replicates.
